Skip to main content
Caplight Logo









Deuce Capital

Deuce Capital

United Kingdomdeucecap.com

Overview

Deuce Capital is a venture capital firm based in the United Kingdom that invests in seed-stage HealthTech businesses.

Year Founded

2024

Portfolio Companies

2

Investments

Deuce Capital investments
CompanyDateStageLead
Chirpy Mood ScienceJan 2026SeedCo-investor
Punto HealthDec 2025SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Deuce Capital based?

Deuce Capital is headquartered in United Kingdom.

When was Deuce Capital founded?

Deuce Capital was founded in 2024.

How many portfolio companies does Deuce Capital have?

Deuce Capital has 2 portfolio companies in Caplight's dataset.

What are some companies in Deuce Capital's portfolio?

Portfolio companies visible on Caplight include Chirpy Mood Science, Punto Health.

What was Deuce Capital's most recent investment shown here?

Deuce Capital's most recent investment in this portfolio sample was in Chirpy Mood Science in 2026.

What sectors does Deuce Capital focus on?

Deuce Capital focuses on Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.

What company stages does Deuce Capital focus on?

Deuce Capital typically invests at the Early stage.

Firmographic Details

HeadquartersUnited Kingdom
Year Founded2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?